Takeda Reports First Quarter FY2018 Results
Takeda Pharmaceutical Company Limited (TOKYO:4502):. Underlying Revenue growth +6.4% with growth in every region. Underlying Revenue grew +6.4%, led by Takeda's Growth Drivers (Gastroenterology, Oncology, Neuroscience and Emerging Markets) ...
from Google Alert - Business https://ift.tt/2OuWtZ3
Takeda Pharmaceutical Company Limited (TOKYO:4502):. Underlying Revenue growth +6.4% with growth in every region. Underlying Revenue grew +6.4%, led by Takeda's Growth Drivers (Gastroenterology, Oncology, Neuroscience and Emerging Markets) ... https://ift.tt/eA8V8J
from Google Alert - Business https://ift.tt/2OuWtZ3
Takeda Pharmaceutical Company Limited (TOKYO:4502):. Underlying Revenue growth +6.4% with growth in every region. Underlying Revenue grew +6.4%, led by Takeda's Growth Drivers (Gastroenterology, Oncology, Neuroscience and Emerging Markets) ... https://ift.tt/eA8V8J
Comments
Post a Comment